Digest Network Come funziona
Network
/
Società
Bl
Non verificato

BlueWind Medical, Ltd.

Di cosa scriviamo

Attrezzature medico-sanitarieBiotecnologiaIndustriaMedicina - VarieSalute

9 comunicati stampa

Guarda tutti i comunicati
05/08/2026
Attrezzature medico-sanitarie
Igiene alimentare
Salute
Farmaceutica
Biotecnologia
BlueWind Medical Receives FDA 510(k) Clearance for Revi® Extend Implant
Fonte
BlueWind Medical, Ltd.
Emittente
Business Wire
1.00
0
14/05/2026
Industria
Attrezzature medico-sanitarie
Salute
BlueWind Medical Secures $47.8 Million Financing to Accelerate Commercialization of Revi® System
Fonte
BlueWind Medical, Ltd.
Emittente
Business Wire
1.00
0
27/02/2026
Eventi
Industria
Salute
Attrezzature medico-sanitarie
Three-Year Data Reinforce Revi® System as the Most Clinically Validated Implantable Tibial Neuromodulation Therapy for Urgency Urinary Incontinence
Fonte
BlueWind Medical, Ltd.
Emittente
Business Wire
1.00
0
16/12/2025
Industria
Salute
Igiene alimentare
Attrezzature medico-sanitarie
Tecnica
Biotecnologia
BlueWind Medical Receives FDA 510(k) Clearance for Enhanced Revi® Wearable Supporting Long-Term Treatment of Urgency Urinary Incontinence
Fonte
BlueWind Medical, Ltd.
Emittente
Business Wire
1.00
0
29/04/2025
Fiere
Industria
Salute
Attrezzature medico-sanitarie
Scienza
Biotecnologia
Revi® System Demonstrates Significant and Sustained Quality of Life Benefits Across All Domains for the Majority of Patients with Urgency Urinary Incontinence at 24 Months
Fonte
BlueWind Medical, Ltd.
Emittente
Business Wire
1.00
0
07/02/2025
Scienza
Tecnica
Attrezzature medico-sanitarie
Medicina - Varie
Tecnologie Varie
Biotecnologia
Salute
Industria
BlueWind Medical Announces Peer-Reviewed Data Showing Excellent Durability of Results for Revi® System at Two Years
Fonte
BlueWind Medical, Ltd.
Emittente
Business Wire
1.00
0
04/11/2024
Industria
Scienza
Tecnica
Attrezzature medico-sanitarie
Medicina - Varie
Biotecnologia
Salute
BlueWind Medical Announces Favorable CMS Decision for 2025 Reimbursement Rates for Revi® System’s Implantable Tibial Neuromodulation Therapy
Fonte
BlueWind Medical, Ltd.
Emittente
Business Wire
1.00
0
31/10/2024
Industria
Scienza
Tecnica
Attrezzature medico-sanitarie
Medicina - Varie
Biotecnologia
Salute
New Research from BlueWind Medical Shows Implantable Tibial Neuromodulation (iTNM), such as the Revi® System, as Effective Alternative to Sacral Neuromodulation (SNM) for Overactive Bladder and Urge Urinary Incontinence
Fonte
BlueWind Medical, Ltd.
Emittente
Business Wire
1.00
0
24/10/2024
Industria
Salute
Medicina - Varie
Sanità
Farmaceutica
Biotecnologia
Two-Year Revi® Therapy Data Reinforce Sustained Efficacy and Safety of Implantable Tibial NeuroModulation in Managing Urgency Urinary Incontinence
Fonte
BlueWind Medical, Ltd.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0